Screener
Bio-Rad Laboratories BIO Clinical Diagnostics — Goodwill, Impaired, Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Goodwill | $493.2 | $421.8 | $915.0 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss?
- Bio-Rad Laboratories (BIO) reported clinical diagnostics — goodwill, impaired, accumulated impairment loss of $293.4M in Q1 2026.
- How has Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss changed year-over-year?
- Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss decreased by 0.0% year-over-year, from $293.4M to $293.4M.
- What is the long-term trend for Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss has grown at a 0.0% compound annual growth rate (CAGR), from $1.17B to $1.17B.
- What does clinical diagnostics — goodwill, impaired, accumulated impairment loss mean?
- The cumulative total of impairment charges recognized against goodwill within the Clinical Diagnostics segment. It reflects the historical reduction in the carrying value of goodwill due to declines in the fair value of the reporting unit.
Ask your AI about Bio-Rad Laboratories's clinical diagnostics — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude